Zimmer Biomet Holdings Inc (Zimmer Biomet) designs, manufactures, and commercializes reconstructive products, dental implants, sports medicine, biologics, extremities, and trauma products; spine, bone cement, craniomaxillofacial and thoracic products; and related surgical products. It serves neurosurgeons, orthopedic surgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare purchasing organizations, healthcare dealers, and other specialists.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Zimmer Biomet's R&D arm focuses on developing new surgical techniques, including robotic techniques, materials, biologics, and product designs. The company is rapidly commercializing new data solutions, surgical techniques, innovative materials, biologics products, and implant and instrument designs. It is also broadening its offerings in certain product categories and exploring new technologies, including artificial intelligence and machine learning, with potential applications in multiple areas. The company aims to identify innovative technologies through acquiring complementary products or businesses, establishing technology licensing arrangements, or forming strategic alliances. The R&D units of Zimmer Biomet are located in Warsaw, Indiana; Montreal, Quebec, Canada; Denver, Colorado; Jacksonville, Florida; Austin, Texas; Zug, Switzerland; and Beijing, China. These units are responsible for managing the company's research and development activities, which include developing new surgical techniques, materials, biologics, and product designs. In FY2025, Zimmer Biomet spent US$458.5 million on its R&D activities, which as a percentage of revenue stood at 5.6%. As of December 2025, the company had more than 2,000 employees working on its R&D activities. As of December 2025, Zimmer Biomet had over 6,000 issued patents and patent applications worldwide related to the technology incorporated in many of its products.